Bills/H.R. 3029119th Congress

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Senate: Received
Cosponsors
3
Introduced
2025-04-28
Last action
2026-07-21

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. SenateLatest

    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

  2. House

    Motion to reconsider laid on the table Agreed to without objection.

  3. House

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)

  4. House

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)

  5. House

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.

  6. House

    Considered under suspension of the rules. (consideration: CR H4666-4667)

  7. House

    Mr. Babin moved to suspend the rules and pass the bill, as amended.

  8. House

    Placed on the Union Calendar, Calendar No. 654.

  9. House

    Reported by the Committee on Science, Space, and Technology. H. Rept. 119-751.

  10. House

    Ordered to be Reported by Voice Vote.

  11. House

    Committee Consideration and Mark-up Session Held

  12. House

    Referred to the House Committee on Science, Space, and Technology.

  13. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

CRS Reports

Nonpartisan Congressional Research Service products citing this bill.

Topics

Legislative subjects

Biological and life sciencesCell biology and embryologyResearch and development